Research & Development
Pathology & AI
Bio-Techne to acquire Namocell
Namocell's instrument portfolio includes Pala, a two-laser system with up to 11 fluorescent detection channels, and Hana, a single-laser system with two fluorescent detection channels.
June 21, 2022
Sherlock gets $5M to advance COVID-19 self-test platform
The Bill & Melinda Gates Foundation provided the grant for the instrument-free, synthetic biology-based molecular diagnostic platform that can be used at home and at room temperature. The platform can be adapted to work on a simple paper strip test or to provide an electrochemical readout that can be read with a mobile phone.
December 15, 2020
Agilent christens new R&D center in Singapore
The NUS-Agilent Hub for Translation & Capture aims to boost clinical diagnostics through biochemical innovation and research data analytics at laboratories based at the university and hospital. Scientists, clinicians, and industry partners will have 1,000 sq m of research space to collaborate and translate biochemical research into clinical applications.
August 19, 2019
Chembio Diagnostics applies for FDA CLIA waiver for HIV, syphilis test
Dr. Fauci invokes Yogi Berra to describe emerging infectious disease challenge
Thermo Fisher Scientific introduces digital PCR liquid-biopsy assays for academic, clinical research
Thermo Fisher Scientific updates Applied Biosystems genetic analyzers to comply with IVDR
Week in Review: Elizabeth Holmes sentenced; good cholesterol worse for some adults; earlier type 2 diabetes diagnosis; and more
Quest Diagnostics completes acquisition of Summa Health outreach lab services business
Page 1 of 1